Adverse effects of stimulant drugs in a community sample of drug users - PubMed (original) (raw)
Comparative Study
Adverse effects of stimulant drugs in a community sample of drug users
S Williamson et al. Drug Alcohol Depend. 1997.
Abstract
A sample of drug users (n = 158) were contacted and interviewed in non-clinical community settings about their use of Ecstasy, cocaine powder, and amphetamines and the adverse effects of these drugs. Subjects reported a wide range of adverse effects including anxiety problems, depression, mood swings, feelings of paranoia, and panic attacks. Sleep and appetite disturbances were the most commonly reported problems. About half of all subjects reported depression and paranoid feelings associated with their stimulant use. Many of those reporting problems stated that these were mild. However, for all drugs, a substantial minority of users reported adverse effects which they rated as 'severe'. Between 30 and 55% of the sample reported having had at least one 'severe' adverse effect (30% cocaine, 35% Ecstasy and 55% amphetamine). There were clear differences between the different drugs in the likelihood and reported severity of adverse effects. Amphetamine use was associated with significantly more adverse effects and with more severe adverse effects than Ecstasy or cocaine. Cocaine powder was associated with the least severe adverse effects. A common pattern of drug use involved the use of depressant drugs such as opiates and benzodiazepines in addition to stimulants. The stimulant and depressant users were more likely than the stimulants-only users to use stimulants by injection and more likely to report adverse effects associated with stimulant use. The stimulant and depressant users were also more likely to have been treated for a drug problem. Approximately a quarter of the sample stated that they had stopped using stimulants up to the point of interview as a result of their bad experiences.
Similar articles
- [Psychiatric illness associated with amphetamines and other stimulants].
Fischer RB. Fischer RB. Psychiatr Prax. 2000 May;27(4):203. Psychiatr Prax. 2000. PMID: 17195515 German. No abstract available. - Drug-related decrease in neuropsychological functions of abstinent drug users.
van Holst RJ, Schilt T. van Holst RJ, et al. Curr Drug Abuse Rev. 2011 Mar;4(1):42-56. doi: 10.2174/1874473711104010042. Curr Drug Abuse Rev. 2011. PMID: 21466500 Review. - Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
Schilt T, de Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W. Schilt T, et al. Psychol Med. 2008 Sep;38(9):1309-17. doi: 10.1017/S0033291707002140. Epub 2007 Nov 8. Psychol Med. 2008. PMID: 17988417 - Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits.
Reske M, Eidt CA, Delis DC, Paulus MP. Reske M, et al. Biol Psychiatry. 2010 Oct 15;68(8):762-9. doi: 10.1016/j.biopsych.2010.04.021. Epub 2010 Jun 3. Biol Psychiatry. 2010. PMID: 20605137 Free PMC article. - [MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
Thomasius R, Schmolke M, Kraus D. Thomasius R, et al. Fortschr Neurol Psychiatr. 1997 Feb;65(2):49-61. doi: 10.1055/s-2007-996309. Fortschr Neurol Psychiatr. 1997. PMID: 9157047 Review. German.
Cited by
- On the persistence of cocaine-induced place preferences and aversions in rats.
Su ZI, Santoostaroam A, Wenzel J, Ettenberg A. Su ZI, et al. Psychopharmacology (Berl). 2013 Sep;229(1):115-23. doi: 10.1007/s00213-013-3086-9. Epub 2013 Apr 9. Psychopharmacology (Berl). 2013. PMID: 23568579 Free PMC article. - Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.
Ettenberg A, Bernardi RE. Ettenberg A, et al. Pharmacol Biochem Behav. 2006 Oct;85(2):393-9. doi: 10.1016/j.pbb.2006.09.007. Epub 2006 Oct 24. Pharmacol Biochem Behav. 2006. PMID: 17064759 Free PMC article. - More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine.
Dlugos AM, Hamidovic A, Hodgkinson CA, Goldman D, Palmer AA, de Wit H. Dlugos AM, et al. Neuropsychopharmacology. 2010 Feb;35(3):613-22. doi: 10.1038/npp.2009.166. Epub 2009 Nov 4. Neuropsychopharmacology. 2010. PMID: 19890266 Free PMC article. Clinical Trial. - CRF1 receptor-deficiency induces anxiety-like vulnerability to cocaine.
Morisot N, Millan MJ, Contarino A. Morisot N, et al. Psychopharmacology (Berl). 2014 Oct;231(20):3965-72. doi: 10.1007/s00213-014-3534-1. Epub 2014 Apr 1. Psychopharmacology (Berl). 2014. PMID: 24687410 - Further evidence of association between amphetamine response and SLC6A2 gene variants.
Dlugos AM, Hamidovic A, Palmer AA, de Wit H. Dlugos AM, et al. Psychopharmacology (Berl). 2009 Oct;206(3):501-11. doi: 10.1007/s00213-009-1628-y. Psychopharmacology (Berl). 2009. PMID: 19727679 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials